[1]
Mazurek, M. et al. 2023. Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity. Journal of Education, Health and Sport. 13, 4 (Feb. 2023), 196–205. DOI:https://doi.org/10.12775/JEHS.2023.13.04.022.